Drug intelligence / Profile preview

YFZ-1QW

Development stage: Preclinical
Lead developer: Yifan Pharmaceutical

Overview

YFZ-1QW is a traditional Chinese medicine (TCM) therapeutic candidate currently under development by Yifan Pharmaceutical. It is positioned in the preclinical stage for the treatment of respiratory diseases. As a TCM-based project, YFZ-1QW likely consists of a proprietary formulation of botanical extracts aimed at addressing inflammatory or infectious conditions of the respiratory tract. Specific details regarding its herbal composition, active constituents, and molecular targets have not been publicly disclosed, which is common for early-stage TCM pipeline entries. The project represents part of Yifan Pharmaceutical's broader strategy to modernize and standardize traditional therapies for major therapeutic areas.

Beyond the preview

Go deeper on YFZ-1QW.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YFZ-1QW.

Explore the full profile